Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes.

Mansouri N, Willis GR, Fernandez-Gonzalez A, Reis M, Nassiri S, Mitsialis SA, Kourembanas S.

JCI Insight. 2019 Nov 1;4(21). pii: 128060. doi: 10.1172/jci.insight.128060.

2.

Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension.

Hudalla H, Michael Z, Christodoulou N, Willis GR, Fernandez-Gonzalez A, Filatava EJ, Dieffenbach P, Fredenburgh LE, Stearman RS, Geraci MW, Kourembanas S, Christou H.

Am J Respir Cell Mol Biol. 2019 Oct;61(4):512-524. doi: 10.1165/rcmb.2018-0232OC.

PMID:
30951642
3.

Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?

Willis GR, Fernandez-Gonzalez A, Reis M, Mitsialis SA, Kourembanas S.

Int J Mol Sci. 2018 Aug 27;19(9). pii: E2534. doi: 10.3390/ijms19092534. Review.

4.

Reply to Muraca et al.: Exosome Treatment of Bronchopulmonary Dysplasia: How Pure Should Your Exosome Preparation Be?

Mitsialis SA, Willis GR, Fernandez-Gonzalez A, Kourembanas S.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):970. doi: 10.1164/rccm.201710-2066LE. No abstract available.

5.

Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency.

Willis GR, Kourembanas S, Mitsialis SA.

Front Cardiovasc Med. 2017 Oct 9;4:63. doi: 10.3389/fcvm.2017.00063. eCollection 2017.

6.

"Good things come in small packages": application of exosome-based therapeutics in neonatal lung injury.

Willis GR, Mitsialis SA, Kourembanas S.

Pediatr Res. 2018 Jan;83(1-2):298-307. doi: 10.1038/pr.2017.256. Epub 2017 Nov 22. Review.

7.

Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.

Willis GR, Fernandez-Gonzalez A, Anastas J, Vitali SH, Liu X, Ericsson M, Kwong A, Mitsialis SA, Kourembanas S.

Am J Respir Crit Care Med. 2018 Jan 1;197(1):104-116. doi: 10.1164/rccm.201705-0925OC.

8.

Therapeutic Applications of Extracellular Vesicles: Perspectives from Newborn Medicine.

Willis GR, Kourembanas S, Mitsialis SA.

Methods Mol Biol. 2017;1660:409-432. doi: 10.1007/978-1-4939-7253-1_34. Review.

PMID:
28828676
9.

Nitrate pharmacokinetics: Taking note of the difference.

James PE, Willis GR, Allen JD, Winyard PG, Jones AM.

Nitric Oxide. 2015 Aug 1;48:44-50. doi: 10.1016/j.niox.2015.04.006. Epub 2015 Apr 29.

PMID:
25937621
10.

Lipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia.

Connolly KD, Willis GR, Datta DB, Ellins EA, Ladell K, Price DA, Guschina IA, Rees DA, James PE.

J Lipid Res. 2014 Oct;55(10):2064-72. doi: 10.1194/jlr.M049726. Epub 2014 Aug 13.

Supplemental Content

Loading ...
Support Center